A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co., Ltd
Lumos Pharma
Nanjing Leads Biolabs Co.,Ltd
iOnctura
University of Rochester
NeoImmuneTech
Inmune Bio, Inc.
Lokon Pharma AB
Bristol-Myers Squibb
University of Maryland, Baltimore
Cytovation AS
Advanced Accelerator Applications
Cytovation AS
Carrick Therapeutics Limited
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Bristol-Myers Squibb
BioAtla, Inc.
University of California, San Diego
BeiGene
Anaveon AG
Palleon Pharmaceuticals, Inc.
PharmaMar
Taiho Oncology, Inc.
Hoffmann-La Roche
Thomas Jefferson University
Esperas Pharma Inc.
Genelux Corporation
Faron Pharmaceuticals Ltd
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Intensity Therapeutics, Inc.
BeiGene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cyteir Therapeutics, Inc.
Yonsei University
Ultimovacs ASA
Peking University Cancer Hospital & Institute
Daiichi Sankyo
Herlev Hospital
GlaxoSmithKline
Cantargia AB
Astex Pharmaceuticals, Inc.
Hutchmed
Basilea Pharmaceutica
Altor BioScience
Servier
Kyowa Kirin Co., Ltd.
Jounce Therapeutics, Inc.
Advaxis, Inc.
Mural Oncology, Inc